Disease/Infection News

RSS

Mucus-based prophylactic gel protects against HIV and herpes transmission

A mucus-based prophylactic gel developed at KTH Royal Institute of Technology has proven 70 percent effective in lab tests against HIV, and 80 percent effective against herpes.

16 Sep 2022

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

University of Alberta research shows how cell membranes play a much larger role than previously understood in allowing spike proteins on viruses to infect cells.

16 Sep 2022

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

The National Institute of Standards and Technology, via an application from the RAPID Manufacturing Institute, awarded the University of Arkansas $699,604 to improve a Wi-Fi nano-biosensor that will be used in a palm-sized, low-cost and wireless SARS-COV-II detection system.

16 Sep 2022

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

A genomic test being developed by a Charlottesville, Va., company can predict a patient's risk of developing severe COVID-19, new research from UVA Health suggests.

16 Sep 2022

Genomic sequencing reveals the course of COVID-19 in Africa

A new study explores the contribution of genomic sequencing to the scientific understanding of COVID-19, and on the introduction of global public health measures via the ability to pick up new variants early enough.

16 Sep 2022

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

A new study maps the escape mutations found in various strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could cause them to escape neutralization by antibodies or detection by rapid antigen tests that rely on antibody binding for a positive result.

16 Sep 2022

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

The COVID-19 pandemic has had many deleterious consequences for health care workers, including the challenges of caring for severely ill patients. Resident physicians, in particular, may have been affected by physical as well as psychological consequences of the pandemic. At present, data are sparse on the perceptions, coping strategies and mental health of residents during COVID-19.

16 Sep 2022

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting.

16 Sep 2022

One year later, 40% of patients with COVID pneumonia still had lung problems

A recent study published in the journal Respiratory Research found impaired lung function and dyspnea amongst severe COVID-19 pneumonia survivors one year post-infection. Meanwhile, many COVID-19 patients developed fibrotic-like sequelae as an aftermath of the infection-associated mild or severe pneumonia.

15 Sep 2022

Study untangles the relation between bacteria and the environment in Lyme disease ecology

Predicting Lyme disease hotspots can help public health officials guide resources and proactive messaging to the public.

15 Sep 2022

Study explores new-onset tinnitus after COVID-19 vaccination

In a new study, researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination.

15 Sep 2022

Survey highlights increase in the public's knowledge about monkeypox

The public's knowledge about monkeypox has increased rapidly in recent weeks though misconceptions and uncertainty persist, and over a quarter of Americans say they are not likely to get vaccinated against monkeypox if they're exposed to it, according to a new Annenberg Public Policy Center (APPC) survey.

15 Sep 2022

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

In a new study, researchers evaluated the factors associated with lower coronavirus disease 2019 (COVID-19) vaccination rates among pregnant individuals in the United States (U.S.).

15 Sep 2022

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

15 Sep 2022

Disease/Infection News

Mucus-based prophylactic gel protects against HIV and herpes transmission

U of A research findings could give scientists the upper hand in tackling SARS-CoV-2

University of Arkansas receives NIST award to improve palm-sized, low-cost and wireless COVID sensor

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

Genomic sequencing reveals the course of COVID-19 in Africa

SARS-CoV-2 N escape mutations do not affect rapid antigen testing

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

SARS-CoV-2 infection and vaccination results in highest and longest-lasting antibody response

One year later, 40% of patients with COVID pneumonia still had lung problems

Study untangles the relation between bacteria and the environment in Lyme disease ecology

Study explores new-onset tinnitus after COVID-19 vaccination

Survey highlights increase in the public's knowledge about monkeypox

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

Study reveals pan-antiviral properties of PDC-109 bovine seminal plasma protein

What is the COVID-19 prevalence among neonates?

Development of improved monoclonal antibodies against SARS-CoV-2

Performance of some COVID-19 home testing kits declined during omicron period, study reveals

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News